Biomarkers in predicting mortality and treatment in hemodialysis patients
Open Access
- 17 March 2009
- journal article
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (21)
- https://doi.org/10.3410/m1-21
Abstract
Biomarkers in predicting mortality and treatment in hemodialysis patientsThis publication has 56 references indexed in Scilit:
- Accuracy of B-Type Natriuretic Peptide Tests to Exclude Congestive Heart FailureArchives of Internal Medicine, 2006
- The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) studyThe American Journal of Cardiology, 2005
- K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.2005
- B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart FailureJournal of the American College of Cardiology, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureThe New England Journal of Medicine, 2002
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Journal of the American College of Cardiology, 1994
- Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.Endocrinology, 1993
- Expression of brain natriuretic peptide gene in human heart. Production in the ventricle.Hypertension, 1991